Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Whitehawk Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −11 vs. Q1 2025
- Shares held
- 29.4M
- −2.38M (−7.5%) vs. Q1 2025
- Total value
- $54.6M
- −$1.61M (−2.9%) vs. Q1 2025
- New holders
- 2
- 9 more added
- Sold out
- 13
- 11 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WHWK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 77 | $198.0M |
| Q1 2026 | 62 | $118.2M |
| Q4 2025 | 48 | $79.2M |
| Q3 2025 | 41 | $54.3M |
| Q2 2025 | 39 | $54.6M |
| Q1 2025 | 50 | $56.2M |
| Q4 2024 | 53 | $47.2M |
| Q3 2024 | 52 | $24.7M |
| Q2 2024 | 65 | $16.7M |
| Q1 2024 | 60 | $30.9M |
| Q4 2023 | 65 | $25.8M |
| Q3 2023 | 73 | $75.3M |
| Q2 2023 | 67 | $100.8M |
| Q1 2023 | 70 | $106.6M |
| Q4 2022 | 76 | $192.2M |
| Q3 2022 | 68 | $212.1M |
| Q2 2022 | 68 | $159.3M |
| Q1 2022 | 55 | $213.8M |
| Q4 2021 | 46 | $294.2M |
| Q3 2021 | 33 | $324.1M |
| Q2 2021 | 43 | $51.0M |
| Q1 2021 | 42 | $34.3M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Whitehawk Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| QVT Financial LP | 4,615,709 | $8.20M | 1.15% | +100,000+2.2% | Added |
| OrbiMed Advisors LLC | 4,166,000 | $7.79M | 0.20% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 3,700,000 | $6.92M | 0.26% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 3,410,402 | $6.38M | 8.90% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 2,849,402 | $5.33M | 0.09% | 00.0% | Unchanged |
| Siren, L.L.C. | 2,082,000 | $3.89M | 0.20% | 00.0% | Unchanged |
| Fan Yu | 2,070,000 | $3.87M | 5.29% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,315,285 | $2.46M | 0.00% | +549,293+71.7% | Added |
| Acorn Capital Advisors, LLC | 1,139,363 | $2.13M | 1.39% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 1,091,417 | $2.04M | 0.12% | −990,583−47.6% | Reduced |
| Ally Bridge Group (NY) LLC | 817,939 | $1.53M | 1.27% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 458,222 | $856.9K | 0.00% | −3,900−0.8% | Reduced |
| Geode Capital Management, LLC | 372,334 | $696.4K | 0.00% | +136,494+57.9% | Added |
| Bridgeway Capital Management, LLC | 315,284 | $589.6K | 0.01% | 00.0% | Unchanged |
| BlackRock, Inc. | 298,320 | $557.9K | 0.00% | +57,071+23.7% | Added |
| Peapod Lane Capital LLC | 242,210 | $452.9K | 0.45% | +807+0.3% | Added |
| Jane Street Group, LLC | 105,310 | $196.9K | 0.00% | +78,650+295.0% | Added |
| Northern Trust Corp | 92,275 | $172.6K | 0.00% | +5,952+6.9% | Added |
| Dimensional Fund Advisors LP | 70,749 | $132.3K | 0.00% | −36,771−34.2% | Reduced |
| State Street Corp | 68,737 | $128.5K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 61,366 | $114.8K | 0.00% | +61,366 | New |
| Citadel Advisors LLC | 28,538 | $53.4K | 0.00% | −68,774−70.7% | Reduced |
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $49.9K | 100.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 11,103 | $20.8K | 0.00% | +11,103 | New |
| UBS Group AG | 8,673 | $16.2K | 0.00% | −26,894−75.6% | Reduced |
| Tower Research Capital LLC (TRC) | 4,098 | $7.66K | 0.00% | +1,543+60.4% | Added |
| US Bancorp | 3,333 | $6.23K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 3,070 | $5.74K | 0.00% | −33−1.1% | Reduced |
| Morgan Stanley | 2,003 | $3.75K | 0.00% | −62,234−96.9% | Reduced |
| Bartlett & Co. Wealth Management LLC | 1,333 | $2.49K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 421 | $787 | 0.00% | −1,341−76.1% | Reduced |
| Bank of America Corp | 411 | $769 | 0.00% | +231+128.3% | Added |
| Russell Investments Group, Ltd. | 386 | $722 | 0.00% | −1,126−74.5% | Reduced |
| Federated Hermes, Inc. | 358 | $669 | 0.00% | −572−61.5% | Reduced |
| TD Waterhouse Canada Inc. | 232 | $432 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 160 | $299 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 19 | $36 | 0.00% | −1−5.0% | Reduced |
| Parallel Advisors, LLC | 8 | $15 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 25 | $0 | 0.00% | 00.0% | Unchanged |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −1,890,245−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −52,486−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −46,698−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −44,823−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −43,158−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −40,969−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −36,774−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −21,800−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,197−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Semmax Financial Advisors Inc. | 0 | $0 | 0.00% | −297−100.0% | Sold out |